DOJ Subpoenas Transgender Clinics And Doctors For Transitioning Children

WASHINGTON — The Justice Department has issued nearly 20 subpoenas to doctors and clinics involved in performing transgender medical procedures on children, a DOJ official announced on Wednesday. 

The Justice Department’s Chad Mizelle made the announcement during the Federal Trade Commission’s workshop on the “Dangers of ‘Gender Affirming-Care’ For Minors” in Washington, D.C. Mizelle shared that DOJ has issued nearly 20 subpoenas against clinics who are engaged in transgender transition attempts, noting that the DOJ’s investigations include healthcare fraud, false statements, and more. 

Mizelle urged Americans to come forward if they could provide information about deceptive practices in the transgender medicine industry, saying Wednesday: “If you are someone who has been harmed please come forward and let us know.”

Immediately following his announcement, Mizelle introduced a panel of detransitioner survivors and parents, including Prisha Mosley, Soren Aldaco, Beth Bourne, Forrest Smith, Helen Spiegel Lee, and Gwen Turecki, individuals who emotionally shared their experiences as they navigated gender transition attempts or helped — or lost — a family member who attempted to transition.

The workshop signals the FTC’s interest in combatting the transgender medicine industry, following the directives of President Donald Trump’s executive orders on protecting children from transgender procedures and combatting radical ideology. 

During Wednesday’s event, doctors, medical ethicists, whistleblowers, detransitioners, and parents of survivors focused on the deceptive practices often found within the transgender medicine industry. One mother, Elvira Syed, broke down sobbing as she described how her daughter ultimately committed suicide.

“I lost my 18-year-old daughter,” she sobs. “To gender ideology.”

The FTC notes, in a description of the event, that “Section 5 of the Federal Trade Commission Act gives the FTC broad authority to protect consumers from unfair or deceptive acts or practices.”

“This authority could be implicated if there is evidence that medical professionals or others omitted warnings about the risks or made false or unsupported claims about the benefits and effectiveness of gender-affirming care for minors,” the description notes. “The workshop will help the FTC to understand whether consumers are being or have been exposed to false or unsupported claims about ‘gender-affirming care’ and to gauge the harms consumers may be experiencing.”